VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,299,153 | -98.4% | 478,695 | +330.6% | 0.00% | – |
| Q1 2022 | $333,477,000 | -34.8% | 111,159 | 0.0% | 0.00% | – |
| Q4 2021 | $511,332,000 | -26.8% | 111,159 | 0.0% | 0.00% | – |
| Q3 2021 | $698,079,000 | -9.8% | 111,159 | -14.0% | 0.00% | – |
| Q2 2021 | $774,075,000 | +22.1% | 129,228 | +28.9% | 0.00% | – |
| Q1 2021 | $634,019,000 | -12.5% | 100,240 | -22.1% | 0.00% | – |
| Q4 2020 | $724,243,000 | +72.5% | 128,640 | +78.3% | 0.00% | – |
| Q3 2020 | $419,855,000 | -19.3% | 72,140 | 0.0% | 0.00% | – |
| Q2 2020 | $520,130,000 | +28.2% | 72,140 | -16.8% | 0.00% | – |
| Q1 2020 | $405,583,000 | -42.2% | 86,663 | -1.0% | 0.00% | – |
| Q4 2019 | $701,942,000 | +25.5% | 87,524 | +7.7% | 0.00% | – |
| Q3 2019 | $559,221,000 | +2.7% | 81,282 | +23.9% | 0.00% | – |
| Q2 2019 | $544,588,000 | +15.9% | 65,613 | +38.8% | 0.00% | – |
| Q1 2019 | $469,755,000 | +129.1% | 47,259 | +76.3% | 0.00% | – |
| Q4 2018 | $205,020,000 | – | 26,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |